ENSURE: summary of safety data1

Image 23@2x.png

Data are n (%)

*Three patients were randomized but did not receive any study medication and were therefore excluded from the safety analysis

Reference

  1. Wu YL, et al. Ann Oncol 2015; 26:1883–9

ENSURE: common adverse events reported in the safety population (1/3) 1

Image 24@2x.png

Data are n (%)

*Three patients were randomized but did not receive any study medication and were therefore excluded from the safety analysis

Reference

  1. Wu YL, et al. Ann Oncol 2015; 26:1883–9

ENSURE: common adverse events reported in the safety population (2/3) 1

Image 25@2x.png

Data are n (%)

*Three patients were randomized but did not receive any study medication and were therefore excluded from the safety analysis

Reference

  1. Wu YL, et al. Ann Oncol 2015; 26:1883–9

ENSURE: common adverse events reported in the safety population (3/3) 1

Image 26@2x.png

Data are n (%)

*Three patients were randomized but did not receive any study medication and were therefore excluded from the safety analysis

Reference

  1. Wu YL, et al. Ann Oncol 2015; 26:1883–9